Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.9 USD | +3.18% | +2.71% | -16.36% |
May. 09 | Earnings Flash (IBEX) IBEX LIMITED Posts Q3 Revenue $126.8M, vs. Street Est of $127M | MT |
May. 09 | Earnings Flash (IBEX) IBEX LIMITED Reports Q3 EPS $0.70, vs. Street Est of $0.52 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.42 for the 2024 fiscal year.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.36% | 274M | C | ||
-20.31% | 213B | B | ||
-19.98% | 58.61B | B- | ||
-0.09% | 58.3B | B | ||
-11.74% | 45.97B | A- | ||
+1.83% | 41.34B | C | ||
-1.28% | 36.11B | B | ||
-8.75% | 28.91B | B | ||
+106.15% | 27.03B | - | ||
+4.60% | 21.91B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- IBEX Stock
- Ratings IBEX Limited